Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | SNCA | P37840 | 2/20 | 0.49 |
| ▸ | CASP6 | P55212 | 3/20 | 0.46 |
| ▸ | NSD2 | O96028 | 2/20 | 0.46 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.46 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.46 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.43 |
| ▸ | RAPGEF4 | Q8WZA2 | 3/20 | 0.42 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.40 |
| ▸ | SUMO2 | P61956 | 1/20 | 0.39 |
| ▸ | SUMO1 | P63165 | 1/20 | 0.39 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.39 |
| ▸ | SENP3 | Q9H4L4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1103769 | 0.89 | CASP6 (0.53) | ALDH1A1HIF1ASNCACASP6NSD2 | |
| SCHEMBL4299904 | 0.86 | ALDH1A1 (0.47) | ALDH1A1HIF1ASNCACASP6NSD2 | |
| SCHEMBL14703497 | 0.81 | SNCA (0.45) | ALDH1A1HIF1ASNCACASP6NSD2 | |
| SCHEMBL7037608 | 0.79 | CASP6 (0.59) | ALDH1A1HIF1ASNCACASP6NSD2 | |
| Ammonia Solution, Strong SCHEMBL28873814 | 0.77 | CASP6 (0.57) | ALDH1A1HIF1ASNCACASP6NSD2 | |
| SCHEMBL15180637 | 0.77 | CASP6 (0.66) | ALDH1A1HIF1ASNCACASP6NSD2 | |
| SCHEMBL4075108 | 0.77 | SNCA (0.69) | ALDH1A1HIF1ASNCACASP6NSD2 | |
| SCHEMBL14469865 | 0.76 | ALDH1A1 (0.64) | ALDH1A1HIF1ASNCACASP6NSD2 | |
| SCHEMBL12679249 | 0.76 | ALDH1A1 (0.48) | ALDH1A1HIF1ASNCACASP6NSD2 | |
| SCHEMBL889908 | 0.76 | SNCA (0.62) | ALDH1A1HIF1ASNCACASP6NSD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9155760-B2 | Method of prophylaxis of bacterial vaginosis | STARPHARMA PTY LIMITED (AU) | 2015-10-13 | — | — | US | disclosed |
| US-20150238557-A1 | METHOD OF TREATMENT OR PROPHYLAXIS OF INFECTIONS OF THE EYE | STARPHARMA PTY LIMITED (AU) | 2015-08-27 | — | — | US | disclosed |
| US-20120295839-A1 | METHOD OF TREATMENT AND PROPHYLAXIS OF BACTERIAL VAGINOSIS | STARPHARMA PTY LIMITED (AU) | 2012-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150238557-A1 | METHOD OF TREATMENT OR PROPHYLAXIS OF INFECTIONS OF THE EYE | TLR9, TLR1, TLR3 | ALDH1A1 1418/4885HIF1A 2304/4885SNCA 2829/4885 |
| US-20120295839-A1 | METHOD OF TREATMENT AND PROPHYLAXIS OF BACTERIAL VAGINOSIS | PCNA, DDOST, TLR8 | ALDH1A1 3736/4885HIF1A 1547/4885SNCA 4217/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.